RVPH: Reviva Pharmaceuticals Holdings, Inc. Stock

by  •  • Comments Off on RVPH: Reviva Pharmaceuticals Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 92.69
Enterprise Value ($M) 87.22
Book Value ($M) -9.98
Book Value / Share -0.21
Price / Book -9.29
NCAV ($M) -10.80
NCAV / Share -0.23
Price / NCAV -8.58

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.39
Return on Equity (ROE) -5.77

Liquidity (mrq)
Quick Ratio 0.39
Current Ratio 0.39

Balance Sheet (mrq) ($M)
Current Assets 6.81
Assets 7.63
Liabilities 17.61
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
5 days ago 13D/A Saxena Parag
12-23 13G CVI Investments, Inc.
12-20 13D/A Bhat Laxminarayan
11-14 13G/A Armistice Capital, Llc 9.99 90.36
11-14 13G Schonfeld Strategic Advisors LLC 5.30
08-14 13G Integrated Core Strategies (us) Llc 5.20
05-31 13D/A Vedanta Partners, Llc 18.50 -2.39
02-14 13G/A Tang Capital Partners Lp 9.99 36.73

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 389,376 1,213,103 32.10
2025-02-03 437,128 1,279,381 34.17
2025-01-31 277,823 920,043 30.20
2025-01-30 331,230 864,817 38.30

(click for more detail)

Similar Companies
RNAZ – TransCode Therapeutics, Inc. RNTX – Rein Therapeutics Inc.
RNXT – RenovoRx, Inc. RZLT – Rezolute, Inc.
SABS – SAB Biotherapeutics, Inc.


Financial data and stock pages provided by
Fintel.io